Expression and activation of P38 MAP kinase in invasive ductal breast cancers: Correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins

Author：          

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.30, Iss.4, 2013-01, pp. : 1943-1948

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Expression of Reactive Oxygen Species-Related Proteins according to Androgen and HER-2 Status in Estrogen Receptor-Negative Breast Cancer

By  

Pathobiology, Vol. 81, Iss. 4, 2014-10 ,pp. : 215-225

Karger

Access to resources Recommend Favorite

Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase

By Fuertes Mercedes B.   Molinero Luciana L.   Toscano Marta A.   Ilarregui Juan M.   Rubinstein Natalia   Fainboim Leonardo   Zwirner Norberto W.   Rabinovich Gabriel A.  

Molecular and Cellular Biochemistry, Vol. 267, Iss. 1-2, 2004-12 ,pp. : 177-185

Springer Publishing Company

Access to resources Recommend Favorite

Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma

By Hartog Hermien  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 725-736

Springer Publishing Company

Access to resources Recommend Favorite

Correlation of Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Progesterone Receptor (PR) Expression as Predicted by Core Biopsy with the Immunohistochemical Results of Surgical Breast Cancer Specimens

By  

Breast Care, Vol. 2, Iss. 2, 2007-04 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma

By                  

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2924-2934

Spandidos Publications

Access to resources Recommend Favorite